all you need
to now about us
ABOUT GLYANCE
Glyance is dedicated to advancing aesthetic medicine through scientifically driven innovation. Focused on developing advanced aesthetic solutions, the company combines pharmaceutical expertise with cutting-edge material science to create products that deliver both immediate visible results and long-term biological benefits.
Glyance offers a range of unique formulations designed to enhance natural appearance, alongside advanced lifting and filling capabilities that ensure exceptional results.
REDEFINING AESTHETIC MEDICINE
Glyance bridges the gap between aesthetic treatments and biological regeneration. Rather than focusing solely on surface-level correction, its technologies are designed to support the skin’s natural processes — combining immediate aesthetic improvement with long-term enhancement of skin quality.
Glyance offers a range of unique formulations designed to enhance natural appearance, alongside advanced lifting and filling capabilities that ensure exceptional results.
INNOVATIVE TECHNOLOGY
At the core of Glyance innovation is a platform-based approach to formulation. By integrating advanced biomaterials such as Hyaluronic Acid and bioactive components, Glyance develops solutions that interact with the skin at a cellular level — enabling both performance and regeneration.
QUALITY &
CLINICAL STANDARDS
Glyance is committed to the highest standards of quality, safety, and clinical performance. All products are developed and manufactured under strict regulatory frameworks, ensuring consistency, reliability, and optimal outcomes.

OUR EXPERTISE
The Glyance team brings together extensive experience in pharmaceuticals, chemistry, and medical device development. This multidisciplinary expertise enables the creation of innovative aesthetic solutions designed to meet a wide range of clinical needs.
Glyance offers a range of unique formulations designed to enhance natural appearance, alongside advanced lifting and filling capabilities that ensure exceptional results.


.avif)